HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xianjuan Kou Selected Research

ampelopsin

6/2017Ampelopsin attenuates the atrophy of skeletal muscle from d-gal-induced aging rats through activating AMPK/SIRT1/PGC-1α signaling cascade.
1/2017Potential Molecular Targets of Ampelopsin in Prevention and Treatment of Cancers.
11/2016Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1/mTOR signal pathway.
11/2015Ampelopsin induces apoptosis in HepG2 human hepatoma cell line through extrinsic and intrinsic pathways: Involvement of P38 and ERK.
1/2012Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xianjuan Kou Research Topics

Disease

3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 06/2017
3Neurodegenerative Diseases (Neurodegenerative Disease)
03/2019 - 06/2017
3Neoplasms (Cancer)
03/2018 - 11/2016
3Atrophy
06/2017 - 01/2016
2Sarcopenia
07/2016 - 01/2016
2Hepatocellular Carcinoma (Hepatoma)
11/2015 - 03/2013
2Inflammation (Inflammations)
01/2012 - 08/2011
1Memory Disorders (Memory Loss)
01/2022
1Neuroinflammatory Diseases
01/2020
1Cognitive Dysfunction
06/2017
1Prostatic Neoplasms (Prostate Cancer)
01/2017
1Breast Neoplasms (Breast Cancer)
01/2017
1Melanoma (Melanoma, Malignant)
01/2017
1Neoplasm Metastasis (Metastasis)
01/2017

Drug/Important Bio-Agent (IBA)

5MicroRNAs (MicroRNA)IBA
01/2020 - 01/2016
5ampelopsinIBA
06/2017 - 01/2012
3Galactose (Galactopyranose)FDA LinkGeneric
06/2017 - 03/2017
3Proteins (Proteins, Gene)FDA Link
06/2017 - 03/2013
2FlavonoidsIBA
01/2017 - 11/2016
1postsynaptic density proteinsIBA
01/2022
1tau Proteins (tau Protein)IBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2020
1Peptides (Polypeptides)IBA
01/2020
1AntioxidantsIBA
03/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2018
1LipidsIBA
03/2018
1ResveratrolIBA
08/2017
1Sirtuin 1IBA
06/2017
1Dynamins (Dynamin)IBA
06/2017
1SpermidineIBA
03/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1dihydromyricetinIBA
11/2016
1CytokinesIBA
01/2016
1Messenger RNA (mRNA)IBA
03/2013
1DNA (Deoxyribonucleic Acid)IBA
03/2013
1Interleukin-6 (Interleukin 6)IBA
08/2011
1arctigeninIBA
08/2011

Therapy/Procedure

2Intraperitoneal Injections
06/2017 - 03/2017
1Drug Therapy (Chemotherapy)
01/2017
1Radiotherapy
01/2017
1Caloric Restriction
07/2016